NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Ho C, Cimon K, Rabb D. Transcatheter Aortic Valve Replacement in Severe Aortic Stenosis: A Review of Comparative Durability and Clinical Effectiveness Beyond 12 Months [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Apr.

Cover of Transcatheter Aortic Valve Replacement in Severe Aortic Stenosis: A Review of Comparative Durability and Clinical Effectiveness Beyond 12 Months

Transcatheter Aortic Valve Replacement in Severe Aortic Stenosis: A Review of Comparative Durability and Clinical Effectiveness Beyond 12 Months [Internet].

Show details

REFERENCES

1.
Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ [Internet] 2012 Jul 31;345:e4710. [cited 2013 Mar 6]; Available from: http://www​.bmj.com/content/345/bmj.e4710. [PubMed: 22849955]
2.
Chu MW, Borger MA, Mohr FW, Walther T. Transcatheter heart-valve replacement: update. CMAJ [Internet] 2010 May 18;182(8):791–795. [cited 2013 Mar 6]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC2871201. [PMC free article: PMC2871201] [PubMed: 20212030]
3.
Statistics Canada. Statistics Canada. Visual Census - Age and sex, Canada [Internet]. Version 2012-09-12. Ottawa: Statistics Canada; 2011. [cited 2013 Mar 6]. Figure 2.1 Percentage of population by broad age groups, Canada, 1996 to 2011 (Catalogue number 98-315-XWE) Available from: http://www12​.statcan​.gc.ca/census-recensement​/2011/dp-pd/vc-rv/index​.cfm?LANG=ENG&VIEW​=D&TOPIC_ID​=2&GEOCODE​=01&CFORMAT=jpg.
4.
Jilaihawi H, Doumanian A, Stegic J, Fontana G, Makkar R. Transcatheter aortic valve implantation: patient selection and procedural considerations. Future Cardiol. 2011 Jul;7(4):499–509. [PubMed: 21797746]
5.
Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J [Internet] 2011 Jan;32(2):205–217. [cited 2013 Jan 23]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC3021388. [PMC free article: PMC3021388] [PubMed: 21216739]
6.
Kempfert J, Lehmann S, Linke A, Rastan A, Van Linden A, Blumenstein J, et al. Latest advances in transcatheter aortic valve implantation. Surg Technol Int. 2010;19:147–154. [PubMed: 20437359]
7.
Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012 Mar;105(3):146–152. [PubMed: 22520797]
8.
The Healthcare Sales & Marketing Network [Internet] Study shows Medtronic CoreValve(R) system efficacy and durability through four years in longest-term industry data available. Newtown Square (PA): Healthcare Sales & Marketing Network, LLC; Aug 28, 2011. [cited 2013 Jan 23]. 2011. Available from: http:​//salesandmarketingnetwork​.com/news_release​.php?ID=2033759.
9.
Salinas P, Moreno R, Lopez-Sendon JL. Transcatheter aortic valve implantation: current status and future perspectives. World J Cardiol [Internet] 2011 Jun 26;3(6):177–185. [cited 2013 Jan 23]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC3139039. [PMC free article: PMC3139039] [PubMed: 21772944]
10.
Mack MJ. Access for transcatheter aortic valve replacement: which is the preferred route? JACC Cardiovasc Interv. 2012 May;5(5):487–488. [PubMed: 22625185]
11.
Neragi-Miandoab S, Skripochnik E, Michler RE. Recently patented and widely used valves for transcatheter aortic valve implantation. Recent Pat Cardiovasc Drug Discov. 2012;7(3):196–205. [PubMed: 23095028]
12.
Health Canada [Internet] Notice of decision for Edwards Sapien transcatheter heart valve. Ottawa: Health Canada; Aug 9, 2011. [cited 2013 Jan 23]. Available from: http://www​.hc-sc.gc.ca​/dhp-mps/prodpharma​/sbd-smd/md-im/sbd_smd​_2011-sapien_thv_176966-eng.php#a2.
13.
Bourantas CV, Farooq V, Onuma Y, Piazza N, van Mieghem NM, Serruys PW. Transcatheter aortic valve implantation: new developments and upcoming clinical trials. EuroIntervention. 2012 Sep 20;8(5):617–627. [PubMed: 22995089]
14.
Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol. 2012 Aug 7;60(6):483–492. [PubMed: 22749306]
15.
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med [Internet] 2010 Oct 21;363(17):1597–1607. [cited 2012 Dec 4]; Available from: http://www​.nejm.org/doi/pdf/10​.1056/NEJMoa1008232. [PubMed: 20961243]
16.
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med [Internet] 2011 Jun 9;364(23):2187–2198. [cited 2013 Jan 23]; Available from: http://www​.nejm.org/doi/full/10​.1056/NEJMoa1103510. [PubMed: 21639811]
17.
Canadian Agency for Drugs and Technologies in Health. Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines [Internet]. Ottawa: CADTH; Oct 28, 2011. [cited 2012 Dec 6]. (Rapid response report: summary with critical appraisal). Available from: http://www​.cadth.ca/media​/pdf/htis/oct-2011​/RC0303-000%20Tavi%20final.pdf.
18.
Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med [Internet] 2009 Jul 21;6(7):e1000097. [cited 2013 Jan 23]; Available from: http://www​.plosmedicine​.org/article/info%3Adoi%2F10​.1371%2Fjournal.pmed.1000097. [PMC free article: PMC2707599] [PubMed: 19621072]
19.
Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol [Internet] 2007;7:10. [cited 2013 Jan 10]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles​/PMC1810543/pdf/1471-2288-7-10.pdf. [PMC free article: PMC1810543] [PubMed: 17302989]
20.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health [Internet] 1998 Jun;52(6):377–384. [cited 2013 Jan 10]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles​/PMC1756728/pdf/v052p00377.pdf. [PMC free article: PMC1756728] [PubMed: 9764259]
21.
Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv. 2012 Jul 1;80(1):128–138. [PubMed: 22415849]
22.
Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012 May 3;366(18):1686–1695. [PubMed: 22443479]
23.
Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012 May 3;366(18):1696–1704. [PubMed: 22443478]
24.
Miller DC, Blackstone EH, Mack MJ, Svensson LG, Kodali SK, Kapadia S, et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012 Apr;143(4):832–843. [PubMed: 22424519]
25.
Wenaweser P, Pilgrim T, Kadner A, Huber C, Stortecky S, Buellesfeld L, et al. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol. 2011 Nov 15;58(21):2151–2162. [PubMed: 22078420]
26.
Sehatzadeh S, Doble B, Xie F, Blackhouse G, Campbell K, Kaulback K, et al. Transcatheter Aortic Valve Implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based analysis (Part B) Ont Health Technol Assess Ser [Internet] 2012 May;12(14):1–62. [cited 2012 Dec 4]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles​/PMC3377530/pdf/ohtas-12-62.pdf. [PMC free article: PMC3377530] [PubMed: 23074424]
27.
Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012 Nov 6;60(19):1864–1875. [PubMed: 23062535]
Copyright © CADTH (April 2013)

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK168895

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (913K)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...